Purchase Order 75N92B18P00026

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $20,509.00 on July 9, 2018, with completion on July 8, 2019. Performance took place in Pleasanton, California. The order was issued on a firm fixed price basis with no small business set-aside. The source does not specify the items or services procured.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $23,084.00 on December 12, 2017. The order covers custom single-cell RNA-sequencing services using 10X Genomics technology. Place of performance is Pleasanton, California. The period of performance runs from December 12, 2017 through December 11, 2018, with an ultimate completion date of January 31, 2018. The contract is firm fixed price with no set-aside category...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $24,084.00 on January 19, 2018. The order procures custom chromium single cell analysis reagents and consumables (3'/5' - 10X Genomics configuration). Performance occurs at 10X Genomics' facility in Pleasanton, California. The period of performance runs from January 19, 2018 through January 18, 2019, with ultimate completion targeted for February 28, 2018. The...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,124.00 on September 20, 2019, with completion on September 27, 2019. The order is a firm fixed price, commercial item acquisition with no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures genomic analysis instruments, consumables, or related bioinformatics products from 10X Genomics' single-cell and spatial transcriptomics...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,887.00 on August 2, 2018, with completion by August 30, 2018. Work is performed in Pleasanton, California. The order is for commercial genomic analysis instruments, consumables, or reagents supplied on a firm fixed price basis. No set-aside applies.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $23,045.50 on November 12, 2019, with completion by November 11, 2020. No set-aside was used. Performance occurs at Bethesda, Maryland. The order is priced on a firm fixed price basis. 10X Genomics supplies single-cell and spatial transcriptomics platforms, reagents, and consumables to federal research agencies; this order procures genomic analysis instruments or...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $21,600 on December 19, 2019. The order, which carries no set-aside designation, covers a platform supporting cell transcriptomics and cell-type identification and discovery. Work is performed at the vendor's facility in Pleasanton, California. The order is firm-fixed-price and concludes on December 26, 2019.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $20,838.50 on July 8, 2019, with completion scheduled for July 22, 2019. No small business set-aside was used. Place of performance is Bethesda, Maryland. The order is firm fixed price for commercial genomics reagents and consumables supplied to the federal research agency, typical of 10X Genomics' NIH-focused business model in single-cell and spatial transcriptomics...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,887.00 on July 5, 2018. Place of performance is Pleasanton, California. The order covers genomic analysis instruments, consumables, or bioinformatics software supplied by the vendor. No set-aside applied. Ultimate completion date is July 5, 2018.</p>

The National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $10,158 firm fixed price purchase order to 10X Genomics, Inc. for products and services to be delivered between July 2023 and July 2024. 10X Genomics, headquartered in Pleasanton, California, will provide genomic analysis tools and technologies to support NIH research initiatives. No subcontractors or set aside designations were indicated. This purchase augments NIH's ongoing...